Gene expression profiling of bone marrow stromal cells from juvenile, adult, aged and osteoporotic rats: With an emphasis on osteoporosis

Bone

Volumn 40, Issue 3, 2007, Pages 700-715

  Xiao, Yin ^a   Fu, Huihua ^b   Prasadam, Indira ^a   Yang, Yaw Ching ^c   Hollinger, Jeffrey O ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c WINDBER RESEARCH INSTITUTE   (United States)

Author keywords

Bone marrow stromal cell; cDNA microarray; Osteoporosis

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; BONE MARROW CELL; DNA MICROARRAY; FEMALE; FINGER DERMATOGLYPHICS; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOME ANALYSIS; ION TRANSPORT; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOPOROSIS; OVARIECTOMY; PATHOGENESIS; PROTEIN METABOLISM; PROTEIN TRANSPORT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STROMA CELL; STUDENT T TEST; UNINDEXED SEQUENCE;

AGE FACTORS; ANIMALS; BONE MARROW CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 33846648670     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.10.021     Document Type: Article

References (41)

1. Seeman E. Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities. Am. J. Med. 95 (1993) 22S-28S
2. Ryan P.J., Blake G.M., and Fogelman I. Postmenopausal screening for osteopenia. Br. J. Rheumatol. 31 (1992) 823-828
3. Fernandes M.S. Fourth International Symposium on Osteoporosis and the Consensus Development Conference. Hong Kong 1993. Acta Med. Port. vol. 6 (1993) 168-170
4. Borojevic R., Roela R.A., Rodarte R.S., Thiago L.S., Pasini F.S., Conti F.M., et al. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression. Leuk. Res. 28 (2004) 831-844
5. Kimmel D., Moran E., and Bogoch E. Animal models of osteopenia or osteoporosis (1999), CRC Press, Boca Raton
6. Uzan B., de Vernejoul M.C., and Cressent M. RAMPs and CRLR expressions in osteoblastic cells after dexamethasone treatment. Biochem. Biophys. Res. Commun. 321 (2004) 802-808
7. Huang Q.Y., Recker R.R., and Deng H.W. Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos. Int. 14 (2003) 701-715
8. Niu T., and Xu X. Candidate genes for osteoporosis. Therapeutic implications. Am. J. Pharmacogenomics 1 (2001) 11-19
9. Dvornyk V., Recker R.R., and Deng H.W. Gene expression studies of osteoporosis: implications for microarray research. Osteoporos. Int. 14 (2003) 451-461
10. Rizzoli R., Bonjour J.P., and Ferrari S.L. Osteoporosis, genetics and hormones. J. Mol. Endocrinol. 26 (2001) 79-94
11. Ho N.C., Jia L., Driscoll C.C., Gutter E.M., and Francomano C.A. A skeletal gene database. J. Bone Miner. Res. 15 (2000) 2095-2122
12. Liu Y.Z., Dvornyk V., Lu Y., Shen H., Lappe J.M., Recker R.R., and Deng H.W. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J. Biol. Chem. 280 (2005) 29011-29016
13. Cappellen D., Luong-Nguyen N.H., Bongiovanni S., Grenet O., Wanke C., and Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B. J. Biol. Chem. 277 (2002) 21971-21982
14. Rho J., Altmann C.R., Socci N.D., Merkov L., Kim N., So H., et al. Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol. 21 (2002) 541-549
15. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277 (2002) 41147-41156
16. Hishiya A., Ikeda K., and Watanabe K. A RANKL-inducible gene Znf216 in osteoclast differentiation. J. Recept. Signal Transduct. Res. 25 (2005) 199-216
17. Lane N.E., Haupt D., Kimmel D.B., Modin G., and Kinney J.H. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat. J. Bone Miner. Res. 14 (1999) 206-214
18. Biosystems A. User Bulletin #2, ABI Prism 7700 Sequence Detection System (2001)
19. Chang B.D., Watanabe K., Broude E.V., Fang J., Poole J.C., Kalinichenko T.V., and Roninson I.B. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4291-4296
20. Guo X., and Liao K. Analysis of gene expression profile during 3T3-L1 preadipocyte differentiation. Gene 251 (2000) 45-53
21. Heller R.A., Schena M., Chai A., Shalon D., Bedilion T., Gilmore J., et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2150-2155
22. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 (2003) R70
23. Ahdjoudj S., Lasmoles F., Holy X., Zerath E., and Marie P.J. Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. J. Bone Miner. Res. 17 (2002) 668-677
24. Kindmark A., Torma H., Johansson A.G., Ljunghall S., and Melhus H. Cellular retinoic acid-binding protein type II is expressed in adult human osteoblasts and in adult liver. Biochem. Biophys. Res. Commun. 189 (1992) 1397-1403
25. Brown E.M., Chattopadhyay N., and Yano S. Calcium-sensing receptors in bone cells. J. Musculoskelet. Neuronal. Interact. 4 (2004) 412-413
26. Blair H.C., Robinson L.J., and Zaidi M. Osteoclast signalling pathways. Biochem. Biophys. Res. Commun. 328 (2005) 728-738
27. Jones K.B., Mollano A.V., Morcuende J.A., Cooper R.R., and Saltzman C.L. Bone and brain: a review of neural, hormonal, and musculoskeletal connections. Iowa Orthop. J. 24 (2004) 123-132
28. Rosen C.J., Ackert-Bicknell C.L., Adamo M.L., Shultz K.L., Rubin J., Donahue L.R., et al. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35 (2004) 1046-1058
29. Parikka V., Vaananen A., Risteli J., Salo T., Sorsa T., Vaananen H.K., et al. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix Biol. 24 (2005) 438-447
30. Pavlidis P., Qin J., Arango V., Mann J.J., and Sibille E. Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem. Res. 29 (2004) 1213-1222
31. Carter P.H., and Schipani E. The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics. Endocr. Metab. Immune Disord. Drug Targets 6 (2006) 59-76
32. Jackson A., Vayssiere B., Garcia T., Newell W., Baron R., Roman-Roman S., et al. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 36 (2005) 585-598
33. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest. 109 (2002) 915-921
34. Roman-Roman S., Garcia T., Jackson A., Theilhaber J., Rawadi G., Connolly T., et al. Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone 32 (2003) 474-482
35. Schubert D., Klar A., Park M., Dargusch R., and Fischer W.H. F-spondin promotes nerve precursor differentiation. J. Neurochem. 96 (2006) 444-453
36. Coss D., Yang L., Kuo C.B., Xu X., Luben R.A., and Walker A.M. Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am. J. Physiol.: Endocrinol. Metab. 279 (2000) E1216-E1225
37. Cauley J.A., Zmuda J.M., Yaffe K., Kuller L.H., Ferrell R.E., and Wisniewski S.R. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk-the study of osteoporotic fractures. J. Bone Miner. Res. 14 (1999) 1175-1181
38. Stewart W.F., Schwartz B.S., Simon D., Kelsey K., and Todd A.C. ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ. Health Perspect. 110 (2002) 501-505
39. Schoon E.J., Muller M.C., Vermeer C., Schurgers L.J., Brummer R.J., and Stockbrugger R.W. Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease?. Gut 48 (2001) 473-477
40. Jie K.S., Knapen M.H., Hellemons B.S., Hamulyak K., and Vermeer C. Vitamin K: current viewpoints in connection with bone metabolism. Ned. Tijdschr. Geneeskd. 139 (1995) 875-880
41. Vermeer C., Jie K.S., and Knapen M.H. Role of vitamin K in bone metabolism. Annu. Rev. Nutr. 15 (1995) 1-22